Biogen abandons Alzheimer's drug Aduhelm to focus on Leqembi, others
Biogen headquarters in Cambridge, Massachusetts, on October 24, 2023. vanessa leroy | Bloomberg | fake images biogen on Wednesday said…
health care industry
We're cutting healthcare stocks ahead of earnings, hedging our bets on China deals
We are selling 95 shares of GE Healthcare at approximately $74. Following Wednesday's transaction, Jim Cramer's Charitable Trust will own…
Novo Nordisk Reaches $500 Billion in Market Value as It Points to Growing Demand for Wegovy and Ozempic
Liselotte Sabroe | afp | fake images Novo Nordisk on Wednesday reported better-than-expected profits for 2023 as sales of its…
Norwegian fund says Novo and Eli Lilly could join trillion-dollar club
A pharmacist displays boxes of Ozempic, an injectable semaglutide drug used to treat type 2 diabetes manufactured by Novo Nordisk,…
Neuralink competitor Synchron buys equity stake in the manufacturer
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet…
Advertising giant Publicis pays $350 million to settle US opioid claims
A Publicis Groupe SA sign at its headquarters in Paris, France, Sunday, July 28, 2013. Balint Porneczi | Bloomberg |…
Merck (MRK) 2023 Fourth Quarter Earnings Report
The Merck & Co. logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York…
January was great for stocks: here are our five best-performing companies of the month
Benchmarks hit record highs as stocks advanced during a busy earnings season.
Fourth-quarter earnings set to be best of 2023
Traders work at the New York Stock Exchange (NYSE) in New York City, USA, on February 1, 2024. Brendan McDermid…
Here are Jim Cramer's quick takeaways on 6 stocks in Friday's news
Clorox: The consumer products giant saw a huge increase in profits. It is also recovering from last year's cyberattack. “Things…